✦ LIBER ✦

Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study

✍ Scribed by Senin, Umberto; Abate, Giuseppe; Fieschi, Cesare; Gori, Guido; Guala, Adriano; Marini, Giorgio; Villardita, Claudio; Parnetti, Lucilla

Book ID: 123344138
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 472 KB
Volume: 1
Category: Article
ISSN: 0924-977X
DOI: 10.1016/0924-977X(91)90004-E

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

578 Galanthamine hydrobromide — Interim

578 Galanthamine hydrobromide — Interim results of a group comparative, placebo controlled, study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer's type

✍ G. Wilcock; D. Wilkinson 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 169 KB

The efficacy of EGb 761 in patients with

The efficacy of EGb 761 in patients with senile dementia of the alzheimer type, a double-blind, placebo-controlled study on different levels of investigation

✍ B. Hofferberth 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 969 KB

Forty patients diagnosed as suffering from senile dementia of the Alzheimer type received either 80mg Ginkgo biloba special extract (GBE)\* or matching placebo t.i.d. for three months in a randomized, double blind study of the efficacy and tolerance of GBE. The patients were assessed using a test ba

A randomized, placebo-controlled, double

A randomized, placebo-controlled, double-blind, clinical trial of sertraline in the treatment of major depression complicating Alzheimer disease: Initial results from the diads study

✍ Lyketsos, Constantine George; Sheppard, Jeannie-Marie E.; Steele, Cynthia D.; Ko 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 187 KB